author-photo

Xiaofen Pan

3

Papers

146

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib.

2013 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (72)
Design, Synthesis, and Biological Evaluation of 3-(1H-1,2,3-Triazol-1-yl)benzamide Derivatives as Potent Pan Bcr-Abl Inhibitors Including the Threonine315→Isoleucine315 Mutant

2012 Journal of Medicinal Chemistry
Show All
- Source
- Cite
- Save
Citations (27)